Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02850704
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
FRR | (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY- 14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO- 1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)- DIONE | A | 2E14 | 0.72 | |
FLQ | N-[6-(ACETYLAMINO)HEXYL]-3',6'- DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN- 1,9'-XANTHENE]-6-CARBOXAMIDE | C | 2FDC | 0.72 | |
HMY | (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy- 3-methoxy-8-methyl-8,9,13,14,15,15a- hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine- 6,12(1aH)-dione | A,B | 3C9W | 0.72 | |
B8L | 3-[(3-SEC-BUTYL-4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-(2-HYDROXY-5-METHOXYBENZOYL)BENZOATE | A | 1REK | 0.7 | |
ADF | 4-{[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN- 1-YL]CARBONYL}PYRROLIDIN-2-YL]METHOXY}- 3-TERT-BUTYLBENZOIC ACID | A | 2G5P | 0.71 | |
MC1 | METHICILLIN ACYL-SERINE | A,B | 1MWU | 0.75 | |
DM4 | 1-O-DEMETHYL-6-DEOXYDOXORUBICIN | A | 1D37 | 0.7 | |
NOD | N-ETHYLHYDROXY-DOXORUBICIN | A | 385D | 0.74 | |
NCG | A | 1MP7 | 0.71 | ||
CN2 | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY- 9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN- 7-YL]ACETAMIDE | A,B,C,D | 1Z2B | 0.7 | |
CN2 | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY- 9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN- 7-YL]ACETAMIDE | A,B,C,D | 3DU7 | 0.7 | |
CN2 | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY- 9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN- 7-YL]ACETAMIDE | A,B,D,F,G | 3EDL | 0.7 | |
CN2 | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY- 9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN- 7-YL]ACETAMIDE | A,B,C,D | 1SA0 | 0.7 | |
DM7 | 4'-DEOXY-4'-IODODOXORUBICIN | A | 1IMR | 0.71 | |
DM7 | 4'-DEOXY-4'-IODODOXORUBICIN | A | 1IMS | 0.71 | |
INX | 2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)- 2-[(3-CARBOXYPROPANOYL)AMINO] - 3-PHENYLPROPANOYL}AMINO)-3-OXO- 3-(PENTYLAMINO)PROPYL]BENZOIC ACID | A | 1G7G | 0.74 | |
941 | 2-(4-{2-TERT-BUTOXYCARBONYLAMINO- 2-[4-(3-HYDROXY-2-METHOXYCARBONYL- PHENOXY)-BUTYLCARBAMOYL]-ETHYL}- PHENOXY)-MALONIC ACID | A | 1PYN | 0.73 | |
BA1 | BALANOL | A | 1BX6 | 0.73 | |
CCG | CALICHEAMICIN GAMMA-1 | A | 2GKC | 0.7 | |
429 | 2-{4-[2-ACETYLAMINO-3-(4-CARBOXYMETHOXY- 3-HYDROXY-PHENYL)-PROPIONYLAMINO]- BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER | A | 1QXK | 0.74 | |
MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D36 | 0.7 | |
MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1R68 | 0.7 | |
MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D35 | 0.7 | |
ABY | N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)- L-CYSTEINYLGLYCINE | A,B | 1PL2 | 0.7 | |
ABY | N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)- L-CYSTEINYLGLYCINE | A,B | 1PL1 | 0.7 | |
DM3 | 6-DEOXYDAUNOMYCIN | A | 1D14 | 0.72 | |
NFN | 6-[[(2-ETHOXY-1-NAPHTHALENYL)CARBONYL]AMINO]- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLATE | A | 1T9W | 0.71 | |
DM2 | DOXORUBICIN | A | 2DR6 | 0.72 | |
DM2 | DOXORUBICIN | A | 1P20 | 0.72 | |
DM2 | DOXORUBICIN | A | 1I1E | 0.72 | |
DM2 | DOXORUBICIN | A | 151D | 0.72 | |
DM2 | DOXORUBICIN | A | 1D12 | 0.72 | |
DM2 | DOXORUBICIN | A | 1DA9 | 0.72 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D15 | 0.72 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D54 | 0.72 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D58 | 0.72 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1QDA | 0.72 | |
DM1 | DAUNOMYCIN | A | 152D | 0.72 | |
DM1 | DAUNOMYCIN | A,B,C,D | 1O0K | 0.72 | |
DM1 | DAUNOMYCIN | A | 1JO2 | 0.72 | |
DM1 | DAUNOMYCIN | A,B | 308D | 0.72 | |
DM1 | DAUNOMYCIN | A | 1D33 | 0.72 | |
DM1 | DAUNOMYCIN | A | 110D | 0.72 | |
DM1 | DAUNOMYCIN | A | 1D11 | 0.72 | |
DM1 | DAUNOMYCIN | A | 427D | 0.72 | |
DM1 | DAUNOMYCIN | A | 2D34 | 0.72 | |
DM1 | DAUNOMYCIN | A | 3F8F | 0.72 | |
DM1 | DAUNOMYCIN | A | 1D10 | 0.72 | |
DM1 | DAUNOMYCIN | A | 1DA0 | 0.72 |